HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA semi-annual agenda

This article was originally published in The Rose Sheet

Executive Summary

A notice of proposed rulemaking for topical antimicrobial consumer products and healthcare antiseptics is slated for release in March, according to FDA's semi-annual agenda, published in Oct. 31 Federal Register. Agency is working to finalize a tentative final monograph for topical antimicrobials published in the June 1994 Federal Register. In October, the Nonprescription Drugs Advisory Committee met to address questions regarding the safety and efficacy of consumer antimicrobials (1"The Rose Sheet" Oct. 24, 2005, p. 9). Additional items on the semi-annual agenda include an amendment to the NPRM for OTC dandruff, seborrheic dermatitis and psoriasis products in December and technical amendments to the final action for skin protectant products marketed as lip protectants in December. The agency expects to release an NPRM for skin bleaching products in March and final action for plaque gingivitis products is slated for October of next year...

Related Content




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts